Strategic Partnerships TIBBIYAH operates as a diversified healthcare holding with multiple arms including Al Faisaliah Medical Systems, Premma, and a Philips joint venture, signaling strong collaboration potential with global equipment providers and turnkey project capabilities for hospital systems.

Recent Leadership New CEO and Chairman appointed in 2026 indicate a transformation drive and appetite for strategic growth, presenting an opening for proposals around organizational efficiency, performance analytics, and expansion of integrated healthcare solutions.

Genomics & Labs Partnership with BGI Genomics and the Genalive clinical genomics lab position TIBBIYAH as a gateway for genomics instrumentation, lab automation, and high-throughput sequencing solutions in the Saudi market.

Acquisition & Growth Recent acquisition of Alhammad Medical Services and a history of mega healthcare projects suggest capacity for large-scale deployments, tenders, and turnkey hospital modernization projects that can benefit from new medical devices and integrated IT systems.

Regional Presence With 50 years of KSA-focused operations and a public listing since 2022, the company is a credible channel for region-wide medical equipment, supply chain optimization, and after-sales services across Saudi Arabia and neighboring markets.